Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of trametinib on the neuropsychological profile of NF1 patients.
Lalancette E, Cantin É, Routhier MÈ, Mailloux C, Bertrand MC, Kiaei DS, Larouche V, Tabori U, Hawkins C, Ellezam B, Décarie JC, Théoret Y, Métras MÉ, McKeown T, Ospina LH, Vairy S, Ramaswamy V, Coltin H, Sultan S, Legault G, Bouffet É, Lafay-Cousin L, Hukin J, Erker C, Caru M, Dehaes M, Jabado N, Perreault S, Lippé S. Lalancette E, et al. Among authors: jabado n. J Neurooncol. 2024 May;167(3):447-454. doi: 10.1007/s11060-024-04624-3. Epub 2024 Mar 5. J Neurooncol. 2024. PMID: 38443693 Clinical Trial.
Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report.
Howie C, Ahmad T, McFadden K, Crooks B, McNeely PD, Walling S, Rutledge R, Sahm F, Hinz F, Jabado N, Kieran M, Erker C. Howie C, et al. Among authors: jabado n. Neurooncol Adv. 2022 Oct 25;4(1):vdac170. doi: 10.1093/noajnl/vdac170. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36479060 Free PMC article. No abstract available.
Bevacizumab in the Treatment of Refractory Brain Edema in High-grade Glioma.
Alsahlawi AK, Michaud-Couture C, Lachance A, Bergeron-Gravel S, Létourneau M, Bourget C, Gould PV, Giannakouros P, Nakada EM, Faury D, Crevier L, Bouffet É, Jabado N, Larouche V, Renzi S. Alsahlawi AK, et al. Among authors: jabado n. J Pediatr Hematol Oncol. 2024 Jan 1;46(1):e87-e90. doi: 10.1097/MPH.0000000000002792. Epub 2023 Nov 30. J Pediatr Hematol Oncol. 2024. PMID: 38032194
Recurrent primary intracranial sarcoma, DICER1-mutant in a pediatric patient with DICER1 syndrome: the importance of molecular testing.
Lachance A, Dimentberg E, Huang S, Bergeron-Gravel S, Bouffet É, Fonseca A, Crevier L, Saikali S, Bourget C, Giannakouros P, Faury D, Jabado N, Foulkes WD, Larouche V, Renzi S. Lachance A, et al. Among authors: jabado n. Childs Nerv Syst. 2024 Jun;40(6):1965-1969. doi: 10.1007/s00381-024-06356-1. Epub 2024 Mar 13. Childs Nerv Syst. 2024. PMID: 38478067
Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.
Dimentberg E, Marceau MP, Lachance A, Bergeron-Gravel S, Saikali S, Crevier L, Bourget C, Hawkins C, Jabado N, Giannakouros P, Renzi S, Larouche V. Dimentberg E, et al. Among authors: jabado n. J Pediatr Hematol Oncol. 2024 May 1;46(4):211-215. doi: 10.1097/MPH.0000000000002853. Epub 2024 Apr 4. J Pediatr Hematol Oncol. 2024. PMID: 38573000 Review.
Disseminated DIG-DIA With a Rare FMR1-RAF1 Fusion With Good Response to Targeted Therapy.
Reeves-Breton L, Allain L, Sathyakumar S, Boyer E, Crevier L, Perreault S, Richer M, Bourget C, Giannakouros P, LeGallou W, Faury D, Laflamme J, Hawkins C, Bouffet E, Jabado N, Coltin H, Renzi S. Reeves-Breton L, et al. Among authors: jabado n. Pediatr Blood Cancer. 2025 Feb;72(2):e31454. doi: 10.1002/pbc.31454. Epub 2024 Nov 19. Pediatr Blood Cancer. 2025. PMID: 39558821 No abstract available.
294 results